-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on NeoGenomics, Raises Price Target to $23

Benzinga·10/29/2026 17:27:21
Listen to the news
TD Cowen analyst Dan Brennan maintains NeoGenomics (NASDAQ:NEO) with a Buy and raises the price target from $19 to $23.